pharma · Urinary Tract Infections · Respiratory Tract Infection Viral · ITRMF
Iterum Therapeutics
Iterum Therapeutics plc
Iterum Therapeutics clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Dublin, IE
- Founded
- 2015
- Employees
- 19
- Programs
- 8
- Drugs
- 8
- Patents
- 3
Iterum Therapeutics projects
8 ClinicalTrials.gov programs sponsored by Iterum Therapeutics.
Iterum Therapeutics has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Azithromycin plus hydroxychloroquine
Iterum Therapeutics plc
Respiratory Tract Infection Viral
1 trial -
Ertapenem
Iterum Therapeutics plc
Intra Abdominal Infections
1 trial -
Sulopenem
Iterum Therapeutics plc
Complicated Urinary Tract Infections
1 trial -
Sulopenem etzadroxil/probenecid
Iterum Therapeutics plc
Urinary Tract Infections
1 trial -
Sulopenem-Etzadroxil/Probenecid
Iterum Therapeutics plc
Uncomplicated Urinary Tract Infections
1 trial -
Sulopenem
Iterum Therapeutics plc
Urinary Tract Infections
1 trial -
sulopenem etzadroxil and probenecid
Iterum Therapeutics plc
Pharmacokinetics After Oral Intake
1 trial -
Ciprofloxacin
Iterum Therapeutics plc
UTI - Lower Urinary Tract Infection
1 trial
Frequently asked questions
How many clinical projects does Iterum Therapeutics have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.